No abstract available
MeSH terms
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Antineoplastic Agents, Immunological / therapeutic use*
-
B7-H1 Antigen / antagonists & inhibitors
-
Chemotherapy, Adjuvant
-
Drug Therapy, Combination / methods*
-
Female
-
Humans
-
Lymphocytes, Tumor-Infiltrating / drug effects
-
Programmed Cell Death 1 Receptor / antagonists & inhibitors
-
Survival Analysis
-
Triple Negative Breast Neoplasms / drug therapy*
-
Triple Negative Breast Neoplasms / pathology
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents, Immunological
-
B7-H1 Antigen
-
Programmed Cell Death 1 Receptor
-
durvalumab
-
atezolizumab
-
pembrolizumab